If your surgeon wants to «debulk» your colon and / or stomach of cancer cells and tumors, keep this in mind: Colon cancer and stomach cancer patients have a lower cure rate
than other cancer patients precisely because surgery and chemotherapy damage the ability of their stomach and colon to properly digest foods.
As a side note, if your surgeon wants to «debulk» your colon and / or stomach of cancer cells and tumors, keep this in mind: colon cancer and stomach cancer patients have a lower cure rate
than other cancer patients precisely because surgery and chemotherapy damages the ability of their stomach and colon to properly digest foods.
Not exact matches
Patients who exercised more
than others had a lower readmission risks following
cancer surgery.
One setback for these therapies which use the body's immune system to fight
cancers is that they are, at times, more effective in certain
patient pools
than others.
And using cells from someone
other than the
cancer patient being treated might trigger an immune response against the foreign cells.
That study showed how a similar model can be used to understand immune response in
patients with pancreatic
cancer who survive longer
than others.
«First mathematical model that predicts immunotherapy success: Researchers also helped craft similar model to predict why some pancreatic
cancer patients survive longer
than others.»
About 52 percent (34 of 66) of
patients had personality - related problems, although sometimes without a formal diagnosis and more
than a majority of
patients had at least one coexisting illness, including
cancer, cardiac disease, diabetes, stroke and
others.
But success could leave a lasting mark on
cancer care, by helping hundreds of thousands of
patients every year, far more
than other genetically targeted therapies.
Even more
than other types of
cancer, melanoma is a disease of aging, with older
patients more frequently diagnosed with the disease and having a worse prognosis.
Many
patients with low - risk prostate
cancer have a lower risk of dying from prostate
cancer than from
other causes.»
The study evaluated 56
patients with ovarian clear cell adenocarcinoma (CCA), an aggressive form of ovarian
cancer that is more likely to be resistant to chemotherapy and to have a poorer prognosis
than other forms of this disease.
The prognosis for HER2 - positive breast
cancer patients is worse
than for those with
other subtypes of the illness.
The research team with international collaborators analysed more
than 100
patient samples from ovarian and
other cancer types to discover a distinct population of cells found in some tumours.
Results reveal that on average, the 13 states allowing the use of medical marijuana had a 24.8 percent lower annual opioid overdose mortality rate after the laws were enacted
than states without the laws, indicating that the alternative treatment may be safer for
patients suffering from chronic pain related to
cancer and
other conditions.
The second question is more difficult to answer
than it might seem because the low prevalence of
cancer and diabetes in Laron
patients is counterbalanced by an abnormally high risk of death from
other causes, especially accidents, alcohol, and convulsive disorders.
More
than half of
patients had at least one type of HPV DNA detectable in their oral rinses, including HPV16, the viral type most commonly associated with oral and
other cancers.
Zeroing in on this kinase was encouraging, Goga said, because
other researchers have shown that genetic - knockout mice that lack the entire family of PIM kinases are slightly smaller
than normal mice, but «basically fine,» indicating that a drug targeting just PIM1 may have manageable levels of toxicity in breast
cancer patients.
Questions to Ask Studies show that
cancer (and
other)
patients who arm themselves with information typically fare better and experience fewer side effects
than those who simply follow doctors» orders, no questions asked.
Chronically - ill
cancer patients have different exercise limitations
than their healthy counterparts and
other concurrent diseases and high symptom burden add challenges in how best to study and implement physical activity programs in lung
cancer patients.
Patients were stratified by number of brain metastases (1 vs. 2 - 3), primary
cancer type (melanoma vs.
other histology) and pre-operative tumor size (less
than vs. greater
than three centimeters).
«While there is understandable excitement around new therapies that enlist the immune system to fight
cancer, we are still in a situation where greater
than half of
patients don't respond in melanoma and the response rate is even worse in
other cancer types,» Hanks said.
Researchers at Washington University School of Medicine in St. Louis have discovered why breast
cancer patients with dense breasts are more likely
than others to develop aggressive tumors that spread.
The study drilled down in particular on
patients who had a high risk of dying from a cause
other than prostate
cancer within 10 years.
«Americans with
cancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries,» says S. Vincent Rajkumar, M.D., of Mayo Clinic Cancer Center, who is one of the au
cancer pay 50 percent to 100 percent more for the same patented drug
than patients in
other countries,» says S. Vincent Rajkumar, M.D., of Mayo Clinic
Cancer Center, who is one of the au
Cancer Center, who is one of the authors.
Additionally, the prognosis for
patients with TNBC is usually poorer
than for those with
other types of breast
cancers.
The researchers also analyzed the effects of methylnaltrexone on another 135
patients from the same trials who had advanced illnesses
other than cancer, such as congestive heart failure, advanced chronic obstructive pulmonary disease or neurologic diseases.
Mass General geneticist Dora Dias - Santagata explains that she and
other pathologists at the hospital's Translational Research Laboratory examine
patients» tumors for more
than 150
cancer - inducing mutations.
In
other words, those likely cured through aggressive treatment were followed more closely
than patients whose
cancers were left untreated.»
The
patients selected from the Netherlands
Cancer Registry had no metastases (spread of the cancer to organs other than the lymph nodes close to the tu
Cancer Registry had no metastases (spread of the
cancer to organs other than the lymph nodes close to the tu
cancer to organs
other than the lymph nodes close to the tumour).
Patients with a prior (within five years) or synchronous malignancy
other than nonmelanoma skin
cancer were excluded.
Patients wait an average of four months before seeking a cancer diagnosis, researchers report at the ESMO ASIA 2016 Congress in Singapore.1 Some patients waited less than a week before seeing a doctor while others waited thre
Patients wait an average of four months before seeking a
cancer diagnosis, researchers report at the ESMO ASIA 2016 Congress in Singapore.1 Some
patients waited less than a week before seeing a doctor while others waited thre
patients waited less
than a week before seeing a doctor while
others waited three years.
In the era of personalized
cancer therapy,
patients with TNBC remain at considerably higher risk of relapse and death
than patients with
other breast
cancer subtypes, due to the aggressive nature of TNBC and the lack of newer targeted therapies for the disease.
«The fact that we found greater cost savings for
cancer patients with more comorbidities
than for those with fewer comorbidities raises the question of whether similar results would be observed in
patients with
other serious illnesses and multimorbidity,» said Professor Peter May of Trinity College Dublin and a former visiting research fellow in the Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai and co-author of the study.
For example, breast
cancer patients with higher vitamin D levels have fewer hot flashes and
other symptoms
than women with lower levels.
«The prolongation in survival seen in the prostate
cancer patients participating in Dr. Sweeney's study is very impressive, dramatically longer
than the typical 2 - 6 month prolongation typically observed in successful studies of
other metastatic adult solid tumors,» said Bruce E. Johnson, MD, Dana - Farber's chief clinical research officer.
Now more
than ever, IASLC needs to take leadership in optimizing the global management of
patients with lung
cancer and
other thoracic malignancies.
They sliced the data by income, race, insurance status and
other factors and found that unmarried
cancer patients are suffering from higher death rates
than their married counterparts.
Patients with
other blood
cancers had response rates > 80 %, and more
than half of study participants experienced complete remission (1).
Researchers have found that treating
patients who have early stage non-small cell lung
cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes
other than cancer.
However, it remains unclear whether
patients with these coexisting problems fare better or worse
than other people when diagnosed with colorectal
cancer, so Adams will use the American Society of Preventive Oncology / Prevent Cancer Foundation / ASCO 2010 Cancer Prevention Research fellowship to answer this que
cancer, so Adams will use the American Society of Preventive Oncology / Prevent
Cancer Foundation / ASCO 2010 Cancer Prevention Research fellowship to answer this que
Cancer Foundation / ASCO 2010
Cancer Prevention Research fellowship to answer this que
Cancer Prevention Research fellowship to answer this question.
Melanoma is more likely
than other skin
cancers to spread beyond the initial tumor site to
other organs, but all the
patients had localized disease.
Doctors at the Abramson
Cancer Center treat more cancers than those at many other cancer centers, and are available to see patients at multiple locations throughout the r
Cancer Center treat more
cancers than those at many
other cancer centers, and are available to see patients at multiple locations throughout the r
cancer centers, and are available to see
patients at multiple locations throughout the region.
November 23, 2015 New test may improve diagnosis and treatment of pancreatobiliary and
other gastrointestinal
cancers By collecting samples from the portal vein — which carries blood from the gastrointestinal tract, including from the pancreas, to the liver — physicians can learn far more about a
patient's pancreatic
cancer than by relying on peripheral blood from a more easily accessed vein in the arm.
For more
than 50 years, Dr. Bertino, who is also a university professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School, has taken care of thousands of
patients with lymphoma and
other blood
cancers, while also trying to unlock the mysteries of these diseases through research.
Overall, researchers showed that regardless of
other risk factors, including age at diagnosis or the initial white blood cell count,
patients with an MRD level of 1 percent or more on day 19 of therapy were far less likely
than other young leukemia
patients to be alive and
cancer - free 10 years later.
Triple - negative breast
cancers represent a challenge for
patients and clinicians, with poorer prognosis and fewer treatment options
than other breast
cancer subtypes.
In one study of more
than 300 autopsy reports, obese
patients were 1.65 times more likely
than others to have significant undiagnosed medical conditions, including bowel disease and lung
cancer.
Armstrong's photo has received more
than 130 comments so far, many of them from
other breast
cancer patients who said they also noticed unusual dimples before their diagnosis.
«But when a six - year study of more
than 16,600 postmenopausal women that was part of the Women's Health Initiative found that the combination of Premarin and Provera seemed to increase the risk of breast
cancer, stroke and heart disease, doctors and
patients suddenly had to consider
other options.»